|
TNFSF12-TNFSF13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.4192999999223E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.0456000000022E-05 |
| Normal-vs-Stage2 |
7.467900E-02 |
| Normal-vs-Stage3 |
2.177000E-04 |
| Normal-vs-Stage4 |
4.615500E-03 |
| Stage1-vs-Stage2 |
9.201600E-01 |
| Stage1-vs-Stage3 |
3.251400E-01 |
| Stage1-vs-Stage4 |
5.419200E-01 |
| Stage2-vs-Stage3 |
5.020400E-01 |
| Stage2-vs-Stage4 |
8.110600E-01 |
| Stage3-vs-Stage4 |
1.875240E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65285000000015E-05 |
| Normal-vs-AfricanAmerican |
6.208300E-02 |
| Normal-vs-Asian |
2.394400E-02 |
| Caucasian-vs-AfricanAmerican |
4.858800E-01 |
| Caucasian-vs-Asian |
9.956000E-01 |
| AfricanAmerican-vs-Asian |
6.153200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.154900E-04 |
| Normal-vs-Female |
1.72585999999031E-05 |
| Male-vs-Female |
3.094400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.410030E-04 |
| Normal-vs-Age(41-60Yrs) |
3.973800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.340920E-03 |
| Normal-vs-Age(81-100Yrs) |
1.270990E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.884800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.206600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.694800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.677200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.142400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.462200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.080200E-01 |
| Classical-VS-Follicular |
3.065200E-01 |
| Classical-VS-Other |
7.815600E-01 |
| Classical-VS-Normal |
4.00019999999834E-05 |
| Tall-VS-Follicular |
6.486200E-01 |
| Tall-VS-Other |
8.503000E-01 |
| Tall-VS-Normal |
5.197600E-02 |
| Follicular-VS-Other |
9.609800E-01 |
| Follicular-VS-Normal |
4.380600E-03 |
| Other-VS-Normal |
3.797200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.2009000000065E-05 |
| Normal-vs-N1 |
3.832600E-04 |
| N0-vs-N1 |
4.007000E-01 |
|
|
